Hemostasis Today

October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Amber Yates: A Major Milestone for the RISE UP Phase 3 Study
Oct 24, 2026, 10:32

Amber Yates: A Major Milestone for the RISE UP Phase 3 Study

Amber Yates, Senior Medical Director and Global Medical Affairs Leader at Agios Pharmaceuticals, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in The Lancet, adding:

“It’s hard to put into words what this means to me. I’m thrilled to share the RISE UP phase 3 results have been published in The Lancet, a culmination of many years of focus and persistence.

When I left academia, for some this decision didn’t make sense. I was stepping away from patient care to pursue an unknown path. True, but this journey has been an indescribable experience.

Every day has been worth it. The challenges, the long hours, the uncertainty – all of it lead to this moment. I’m so grateful to work on this team – the dedication, always patient focused.

This is not the end, it is the beginning.”

Title: Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial

Authors: C. Silva Pinto, Ana Sofia Leal, Carlos Marques, Patrícia Martinho, Filipa Pires, Jorge Felix, Cristina Oliveira, M. Fátima Rodrigues, Artur Pereira, Olena Lavrukina, Laura Rodrigues, Tiago Luís, Teresa Sevivas, Emanuel Rodrigues, Luís Moura, Liberato Lobo, Anabela Ferrão, Ana Cristovão Ferreira, Sílvia do Amaral, Raquel Maia, Paula Kjollerstrom, Filipe Gonçalves, Luciana Gonçalves, Joana Cabral, Madalena Calheiros, Joana Oliveira, Shally Antonio, Tabita Maia, Catarina Geraldes, Teresa Fidalgo

Amber Yates: A Major Milestone for the RISE UP Phase 3 Study

Other posts featuring Amber Yates on Hemostasis Today.